©2024 Stanford Medicine
Acute Treatment of Bipolar II Depression
Not Recruiting
Trial ID: NCT00074776
Purpose
This study will compare the medications lithium and lamotrigine (Lamictal®) in treating
depression in individuals with bipolar II disorder.
Official Title
Acute Treatment of Bipolar II Depression
Stanford Investigator(s)
Trisha Suppes, MD, PhD
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Eligibility
Inclusion Criteria:
- Current diagnosis of bipolar II disorder
Exclusion Criteria:
- Use of lithium or lamotrigine
- Intolerance to lithium or lamotrigine
- Substance abuse or dependence within the last month
- Suicidal thoughts
- Unstable medical conditions
- Pregnancy or breast-feeding
- Stable on current medications
- Use of fluoxetine (Prozac) within 2 weeks of study
- Require an antipsychotic medication
- Do not speak or read English
Intervention(s):
drug: Lithium
drug: Lamotrigine
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305